| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/20/2013 | CN102973692A Houshuning dispersible tablet and preparation method of same |
| 03/20/2013 | CN102973679A Preparation method of total alkaloids extract in aconitum medical material or processed products of aconitum plants |
| 03/20/2013 | CN102973664A Toothache extended action tablet and preparation method |
| 03/20/2013 | CN102973663A Toothache treatment aerosol and preparation method |
| 03/20/2013 | CN102973653A Preparation method of tanshinone extract and water soluble substance thereof |
| 03/20/2013 | CN102973639A Cervical vertebra therapeutic medicine composition |
| 03/20/2013 | CN102973636A Common threewingnut root microemlusion-based gel preparation and preparation method thereof |
| 03/20/2013 | CN102973632A Bone setting ointment |
| 03/20/2013 | CN102973621A Three-gout sandalwood oral liquid and detecting method thereof |
| 03/20/2013 | CN102973591A Application of alginic acid in preparing medicament for treating serious hepatitis |
| 03/20/2013 | CN102973590A Application of alginic acid in preparing medicament for treating hepatic fibrosis |
| 03/20/2013 | CN102973587A Application of carrageenan in preparing medicament for treating serious hepatitis |
| 03/20/2013 | CN102973576A Medicine powder for treating dermatosis |
| 03/20/2013 | CN102973562A Anti-inflammatory composition |
| 03/20/2013 | CN102973560A Novel method of applying matrine to treating eczematous dermatitis |
| 03/20/2013 | CN102973554A Medical application of alantolactone |
| 03/20/2013 | CN102973553A Abirritation application of guaiane type sesquiterpene capsaicin receptor antagonist |
| 03/20/2013 | CN102973545A Abirritation application of dicaffeoylquinic acid type capsaicin receptor antagonist |
| 03/20/2013 | CN102973530A Febuxostat double-layer enteric-coated tablet and preparation method thereof |
| 03/20/2013 | CN102973479A Manufacturing method of facial mask paper |
| 03/20/2013 | CN102973469A Mild hand sanitizer containing camellia oil cake extract |
| 03/20/2013 | CN102973453A Medicated toothpaste and preparation method thereof |
| 03/20/2013 | CN102973417A Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes |
| 03/20/2013 | CN102441145B Medicament for treating lumbar disc herniation and cervical spondylosis |
| 03/20/2013 | CN102357224B Aromatic pain-alleviating plaster |
| 03/20/2013 | CN102327361B Traditional Chinese medicine preparation for treating heel pain |
| 03/20/2013 | CN102274474B Medicinal liquor for treating rheumatic diseases |
| 03/20/2013 | CN102274342B External sticking plaster |
| 03/20/2013 | CN102233010B Children bellyache patch, and preparation method thereof |
| 03/20/2013 | CN102204998B Method for measuring content of verbascoside in callicarpa nudiflora preparation |
| 03/20/2013 | CN102188495B Preparation method of Chilian oral liquid |
| 03/20/2013 | CN102126933B Diphenyl propane lignan compound and preparation method thereof |
| 03/20/2013 | CN102091235B Medicament for treating vertebara swell and production method thereof |
| 03/20/2013 | CN102091168B Detection method for Chinese medicine preparation Xuefuzhuyu capsule |
| 03/20/2013 | CN102058836B Medicament composition with effects of resisting thrombus, reducing blood pressure and treating leukemia |
| 03/20/2013 | CN102048843B Qingpeng emplastrum for reducing swelling and stopping pain and preparation method thereof |
| 03/20/2013 | CN102002050B Bisbenzylisoquinoline derivative and preparation and application thereof |
| 03/20/2013 | CN101933960B Method for identifying medicinal cyathula root and easily-confused species thereof |
| 03/20/2013 | CN101785789B Method for preparing animal gall powder |
| 03/20/2013 | CN101778830B Particulates of a crth2 antagonist |
| 03/20/2013 | CN101648865B Polyphenol acrylic acid derivative and application thereof in medicaments |
| 03/20/2013 | CN101486714B Novel oxazine compound and use for preventing platelet aggregation |
| 03/20/2013 | CN101480429B Chinese medicine preparation for treating external infection |
| 03/20/2013 | CN101460505B Thiazolyl-dihydroquinazolines |
| 03/20/2013 | CN101304756B Herbal composition for inflammatory disorders |
| 03/19/2013 | US8401233 Systems and methods for remote work sessions |
| 03/19/2013 | US8399666 5-lipoxygenase-activating protein (FLAP) inhibitors |
| 03/19/2013 | US8399477 (Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor |
| 03/19/2013 | US8399414 Analgesics |
| 03/19/2013 | US8398998 Therapeutic composition comprising a botulinum neurotoxin |
| 03/19/2013 | US8398980 Subtypes of humanized antibody against interleuken-6 receptor |
| 03/19/2013 | CA2706872C Intermediates for the preparation of lipoxin a4 analogs |
| 03/19/2013 | CA2682629C Pyrimidine hydrazide compounds as pgds inhibitors |
| 03/19/2013 | CA2471702C Human monoclonal antibodies against cd30 |
| 03/19/2013 | CA2435363C New inhibitors against galectins |
| 03/14/2013 | WO2013036914A1 Materials and methods for modulating immune responses |
| 03/14/2013 | WO2013036303A2 Induced tolerogenic dendritic cells to reduce systemic inflammatory cytokines |
| 03/14/2013 | WO2013036302A1 Induced tolerogenic dendritic cells for generating cd8+ regulatory t cells |
| 03/14/2013 | WO2013036301A1 Induced tolerogenic dendritic cells for inducing regulatory b cells |
| 03/14/2013 | WO2013036300A1 Compositions and methods related to induced tolerogenic dedritic cells externally loaded with mhc class i-restricted epitopes |
| 03/14/2013 | WO2013036297A1 Therapeutic protein-specific induced tolerogenic dendritic cells and methods of use |
| 03/14/2013 | WO2013036295A1 Antigen-specific induced tolerogenic dendritic cells to reduce antibody responses |
| 03/14/2013 | WO2013036294A1 Antigen-specific induced tolerogenic dendritic cells to reduce cytotoxic t lymphocyte responses |
| 03/14/2013 | WO2013036286A2 Retinal cyclodextrin acetals and hemiacetals for clarifying skin complexion |
| 03/14/2013 | WO2013036153A1 An anthracycline for the treatment of sepsis |
| 03/14/2013 | WO2013035837A1 Method for suppressing decrease in viscosity of aqueous liquid agent |
| 03/14/2013 | WO2013034900A1 Caninised antibodies and method for the production of same |
| 03/14/2013 | WO2013034746A1 Anti-inflammatory compositions comprising malvidin - 3 - o - beta-glucoside and a propolis extract |
| 03/14/2013 | WO2012178160A3 Materials and methods for modulating immune responses |
| 03/14/2013 | WO2012176061A9 Trpv1 antagonists including dihydroxy substituent and uses thereof |
| 03/14/2013 | WO2012138846A3 Method and compositions comprising small rna agonist and antagonists to modulate inflammation |
| 03/14/2013 | US20130066069 Processes for preparing substituted pyrimidines |
| 03/14/2013 | US20130065938 Mutator Activity Induced by microRNA-155 (miR-155) Links Inflammation and Cancer |
| 03/14/2013 | US20130065934 Fatty acid cox inhibitor derivatives and their uses |
| 03/14/2013 | US20130065926 N-piperidinyl acetamide derivatives as calcium channel blockers |
| 03/14/2013 | US20130065918 Soluble guanylate cyclase activators |
| 03/14/2013 | US20130065914 Halogen or cyano substituted thieno [2,3-d]pyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions |
| 03/14/2013 | US20130065909 Fatty acid fumarate derivatives and their uses |
| 03/14/2013 | US20130065908 Dihydrofuro pyrimidines as akt protein kinase inhibitors |
| 03/14/2013 | US20130065902 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators |
| 03/14/2013 | US20130065899 Heteroaryl compounds and uses thereof |
| 03/14/2013 | US20130065895 Pyrazolopyridine, Pyrazolopyrazine, Pyrazolopyrimidine, Pyrazolothiophene and Pyrazolothiazole Compounds as MGLUR4 Allosteric Potentiators, Compositions, and Methods of Treating Neurological Dysfunction |
| 03/14/2013 | US20130065894 6-(4-HYDROXY-PHENYL)-3-STYRYL-1H-PYRAZOLO[3,4-b]PYRIDINE-4-CARBOXYLIC ACID AMIDE DERIVATIVES AS KINASE INHIBITORS |
| 03/14/2013 | US20130065889 2,5-disubstituted arylsulfonamide ccr3 antagonists |
| 03/14/2013 | US20130065885 Oral therapeutic compound delivery system |
| 03/14/2013 | US20130065883 Triazolo [4, 5- B] Pyridin Derivatives |
| 03/14/2013 | US20130065882 VLA-4 inhibitory drug |
| 03/14/2013 | US20130065881 Tricyclic Compounds for Use as Kinase Inhibitors |
| 03/14/2013 | US20130065880 Compounds as tyrosine kinase modulators |
| 03/14/2013 | US20130065873 Metal complexes |
| 03/14/2013 | US20130065872 Synthesis of syrbactin proteasome inhibitors |
| 03/14/2013 | US20130065870 Treatment of pain with topical diclofenac |
| 03/14/2013 | US20130065866 Dentinal drug delivery composition and screening method |
| 03/14/2013 | US20130065863 Nitroxyl (hno) releasing compounds and uses thereof in treating diseases |
| 03/14/2013 | US20130065858 Compounds useful as raf kinase inhibitors |
| 03/14/2013 | US20130065845 Triazole Compounds and Methods of Making and Using the Same |
| 03/14/2013 | US20130065843 Phenolic Compositions Derived From Apple Skin And Uses Thereof |
| 03/14/2013 | US20130065842 COMPOUNDS AS RORyT MODULATORS AND USES THEREOF |
| 03/14/2013 | US20130065840 Method and peptide for regulating cellular activity |
| 03/14/2013 | US20130065838 Sap variants and their use |